Literature DB >> 29465611

Mitochondrial DNA Deletions With Low-Level Heteroplasmy in Adult-Onset Myopathy.

Doris G Leung1,2, Julie S Cohen1, Elizabeth Harlan Michelle2, Renkui Bai3, Andrew L Mammen2,4,5, Lisa Christopher-Stine5.   

Abstract

We report the cases of 2 patients who presented to our Myositis Center with myalgias and elevated creatine kinase levels. Muscle biopsy showed pathological features consistent with mitochondrial myopathy. In both cases, a single large deletion in mitochondrial DNA at low-level heteroplasmy was identified by next-generation sequencing in muscle tissue. In 1 case, the deletion was identified in muscle tissue but not blood. In both cases, the deletion was only identified on next-generation sequencing of muscle mitochondrial DNA and missed on array comparative genome hybridization testing. These cases demonstrate that next-generation sequencing of mitochondrial DNA in muscle tissue is the most sensitive method of molecular diagnosis for mitochondrial myopathy due to mitochondrial DNA deletions.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29465611      PMCID: PMC5824425          DOI: 10.1097/CND.0000000000000200

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN: 1522-0443


  24 in total

1.  Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers.

Authors:  Entela Bua; Jody Johnson; Allen Herbst; Bridget Delong; Debbie McKenzie; Shahriar Salamat; Judd M Aiken
Journal:  Am J Hum Genet       Date:  2006-07-07       Impact factor: 11.025

Review 2.  Diagnostic challenges of mitochondrial DNA disorders.

Authors:  Lee-Jun C Wong
Journal:  Mitochondrion       Date:  2006-12-12       Impact factor: 4.160

Review 3.  The role of mitochondria in statin-induced myopathy.

Authors:  Maria Apostolopoulou; Alberto Corsini; Michael Roden
Journal:  Eur J Clin Invest       Date:  2015-06-15       Impact factor: 4.686

4.  Simultaneous detection and quantification of mitochondrial DNA deletion(s), depletion, and over-replication in patients with mitochondrial disease.

Authors:  Ren-Kui Bai; Lee-Jun C Wong
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

5.  New insights into the metabolic consequences of large-scale mtDNA deletions: a quantitative analysis of biochemical, morphological, and genetic findings in human skeletal muscle.

Authors:  R Schröder; S Vielhaber; F R Wiedemann; C Kornblum; A Papassotiropoulos; P Broich; S Zierz; C E Elger; H Reichmann; P Seibel; T Klockgether; W S Kunz
Journal:  J Neuropathol Exp Neurol       Date:  2000-05       Impact factor: 3.685

Review 6.  Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.

Authors:  Sumit Parikh; Amy Goldstein; Amel Karaa; Mary Kay Koenig; Irina Anselm; Catherine Brunel-Guitton; John Christodoulou; Bruce H Cohen; David Dimmock; Gregory M Enns; Marni J Falk; Annette Feigenbaum; Richard E Frye; Jaya Ganesh; David Griesemer; Richard Haas; Rita Horvath; Mark Korson; Michael C Kruer; Michelangelo Mancuso; Shana McCormack; Marie Josee Raboisson; Tyler Reimschisel; Ramona Salvarinova; Russell P Saneto; Fernando Scaglia; John Shoffner; Peter W Stacpoole; Carolyn M Sue; Mark Tarnopolsky; Clara Van Karnebeek; Lynne A Wolfe; Zarazuela Zolkipli Cunningham; Shamima Rahman; Patrick F Chinnery
Journal:  Genet Med       Date:  2017-07-27       Impact factor: 8.822

7.  SLC25A4 and C10ORF2 Mutations in Autosomal Dominant Progressive External Ophthalmoplegia.

Authors:  Kyung-Pil Park; Hyang-Sook Kim; Eun-Sook Kim; Young-Eun Park; Chang-Hoon Lee; Dae-Seong Kim
Journal:  J Clin Neurol       Date:  2011-03-31       Impact factor: 3.077

8.  Application of dual-genome oligonucleotide array-based comparative genomic hybridization to the molecular diagnosis of mitochondrial DNA deletion and depletion syndromes.

Authors:  A Craig Chinault; Chad A Shaw; Ellen K Brundage; Lin-Ya Tang; Lee-Jun C Wong
Journal:  Genet Med       Date:  2009-07       Impact factor: 8.822

9.  Clinical application of whole-exome sequencing across clinical indications.

Authors:  Kyle Retterer; Jane Juusola; Megan T Cho; Patrik Vitazka; Francisca Millan; Federica Gibellini; Annette Vertino-Bell; Nizar Smaoui; Julie Neidich; Kristin G Monaghan; Dianalee McKnight; Renkui Bai; Sharon Suchy; Bethany Friedman; Jackie Tahiliani; Daniel Pineda-Alvarez; Gabriele Richard; Tracy Brandt; Eden Haverfield; Wendy K Chung; Sherri Bale
Journal:  Genet Med       Date:  2015-12-03       Impact factor: 8.822

10.  An "inflammatory" mitochondrial myopathy. A case report.

Authors:  Michelangelo Mancuso; Daniele Orsucci; Elena Caldarazzo Ienco; Giulia Ricci; Greta Ali; Adele Servadio; Gabriella Fontanini; Massimiliano Filosto; Valentina Vielmi; Anna Rocchi; Lucia Petrozzi; Annalisa Logerfo; Gabriele Siciliano
Journal:  Neuromuscul Disord       Date:  2013-08-08       Impact factor: 4.296

View more
  1 in total

Review 1.  Update Review about Metabolic Myopathies.

Authors:  Josef Finsterer
Journal:  Life (Basel)       Date:  2020-04-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.